Article Listing - Biogen halts Antova trials, citing serious adverse events

ANTIBIOTICS AND OTITIS MEDIA

4 May 1992

A meta-analysis of 10 studies has confirmed that antibiotics are effective as a short-term cure for effusive otitis media. The...

OTC LABELING "MISLEADS CONSUMERS"

4 May 1992

The US Food and Drug Administra-tion has relied too much on the pharmaceutical industry to monitor the safety of over-the-counter...

PAXIL, NOT AROPAX

4 May 1992

The US trade name for SmithKline Beecham's paroxetine is to be Paxil, and not Aropax. A New Drug Application for...

ALGERIA/MOROCCO PHARMACEUTICAL LINKS

4 May 1992

A delegation from the Encopharm pharmaceutical enterprise in Constantine in eastern Algeria is planning to visit Morocco to discuss the...

KEMRON COMES UNDER ATTACK

4 May 1992

The US National Institutes of Health's AIDS Research Advisory Committee (ARAC) has published a statement which concludes that the Kenya-developed...

STOCK MARKET COMMENTARY: TOKYO

4 May 1992

TOKYO: edged up by 2.2% to 17,450.52 yen in continued light trading volume last week. The early part of the...

S-P BACKs TOKYO INSTITUTE WITH $2.5m

4 May 1992

An endowment of $2.5 million has been established by Schering-Plough for the Bioscience and Biotechnology faculty of the Tokyo Institute...

GRACE AND DU PONT GENTECH AGREE'T

4 May 1992

The world's largest specialty chemicals and materials company, US-based W R Grace & Co, and Du Pont have announced the...

FRENCH HOMEOPATHIC DRUGS COMPETITION

4 May 1992

Competition in France between the two leading producers of homeopathic medicines, Boiron and Dolisos, has intensified, despite a 6.2 million...

B-MS EXPECTS 2nd QTR GROWTH INCREASE

4 May 1992

A second-quarter profit increase higher than that reported in the first quarter (Marketletter April 27) is expected by Bristol-Myers Squibb....

Showing 94041-94050 of 95321 articles

Go to beginningPreviousNextGo to end